-LRB-/-LRB- During/IN its/PRP$ centennial/JJ year/NN ,/, The/DT Wall/NNP Street/NNP Journal/NNP will/MD report/VB events/NNS of/IN the/DT past/JJ century/NN that/DT stand/NN as/IN milestones/NNS of/IN American/JJ business/NN history/NN ./. -RRB-/-RRB-
LUTHER/NNP BURBANK/NNP CROSS-BRED/VBD PLANTS/NNS to/TO produce/VB the/DT billion-dollar/JJ Idaho/NNP potato/NN ./.
Bioengineers/NNS set/VBD out/RP to/TO duplicate/VB that/DT feat/NN --/: scientifically/RB and/CC commercially/RB --/: with/IN new/JJ life/NN forms/NNS ./.
In/IN #/CD ,/, James/NNP Watson/NNP and/CC his/PRP$ colleagues/NNS unlocked/VBD the/DT double/JJ helix/NN of/IN DNA/NN -LRB-/-LRB- deoxyribonucleic/JJ acid/NN -RRB-/-RRB- ,/, the/DT genetic/JJ key/NN to/TO heredity/NN ./.
Twenty/CD years/NNS later/RB ,/, two/CD California/NNP academics/NNS ,/, Stanley/NNP Cohen/NNP and/CC Herbert/NNP Boyer/NNP ,/, made/VBD ``/`` recombinant/JJ ''/'' DNA/NN ,/, transplanting/VBG a/DT toad/NN 's/POS gene/NN into/IN bacteria/NNS ,/, which/WDT then/RB reproduced/VBD toad/NN genes/NNS ./.
When/WRB Boyer/NNP met/VBD Robert/NNP Swanson/NNP ,/, an/DT M.I.T.-trained/JJ chemist-turned-entrepreneur/NN in/IN #/CD ,/, they/PRP saw/VBD dollar/NN signs/NNS ./.
With/IN $/$ #/CD apiece/RB and/CC an/DT injection/NN of/IN outside/JJ capital/NN ,/, they/PRP formed/VBD Genentech/NNP Inc/NNP ./.
Commercial/JJ gene-splicing/NN was/VBD born/VBN ./.
Genentech/NNP 's/POS first/JJ product/NN ,/, a/DT brain/NN protein/NN called/VBD somatostatin/NN ,/, proved/VBD its/PRP$ technology/NN ./.
The/DT next/JJ to/TO be/VB cloned/VBN ,/, human/JJ insulin/NN ,/, had/VBD market/NN potential/NN and/CC Genentech/NNP licensed/VBD it/PRP to/TO Eli/NNP Lilly/NNP ,/, which/WDT produced/VBD #/CD %/NN of/IN the/DT insulin/NN used/VBN by/IN #.#/CD million/CD U.S./NNP diabetics/NNS ./.
Their/PRP$ laboratory/NN credentials/NNS established/VBN ,/, Boyer/NNP and/CC Swanson/NNP headed/VBD for/IN Wall/NNP Street/NNP in/IN #/CD ./.
At/IN the/DT time/NN ,/, Genentech/NN had/VBD only/RB one/CD profitable/JJ year/NN behind/IN it/PRP -LRB-/-LRB- a/DT modest/JJ $/$ #,#/CD on/IN revenue/NN of/IN $/$ #.#/CD million/CD in/IN #/CD -RRB-/-RRB- and/CC no/DT product/NN of/IN its/PRP$ own/JJ on/IN the/DT market/NN ./.
Nonetheless/RB ,/, the/DT $/$ #/CD million/CD issue/NN they/PRP floated/VBD in/IN #/CD opened/VBD at/IN $/$ #/CD and/CC leaped/VBD to/TO $/$ #/CD within/IN #/CD minutes/NNS ./.
The/DT trip/NN from/IN the/DT test/NN tube/NN was/VBD not/RB without/IN snags/NNS ./.
Boyer/NNP and/CC Cohen/NNP ,/, for/IN instance/NN ,/, both/DT still/RB university/NN researchers/NNS ,/, had/VBD to/TO be/VB talked/VBN into/IN applying/VBG for/IN a/DT patent/NN on/IN their/PRP$ gene-splicing/NN technique/NN --/: and/CC then/RB the/DT Patent/NNP Office/NNP refused/VBD to/TO grant/VB it/PRP ./.
That/DT judgment/NN ,/, in/IN turn/NN ,/, was/VBD reversed/VBN by/IN the/DT U.S./NNP Supreme/NNP Court/NNP ,/, leaving/VBG Cohen/NNP and/CC Boyer/NNP holding/VBG the/DT first/JJ patents/NNS for/IN making/VBG recombinant/JJ DNA/NNP -LRB-/-LRB- now/RB assigned/VBN to/TO their/PRP$ schools/NNS -RRB-/-RRB- ./.
Gene-splicing/NN now/RB is/VBZ an/DT integral/JJ part/NN of/IN the/DT drug/NN business/NN ./.
Genentech/NN 's/POS #/CD sales/NNS were/VBD $/$ #/CD million/CD ,/, both/CC from/IN licensing/NN and/CC its/PRP$ own/JJ products/NNS ./.
